| Mrs Nancy Yvonne Spivey, PHARMD | |
|
1278 N Lafayette Dr, Pharmacy Dept, Sumter, SC 29150-2964 | |
| (803) 774-4500 | |
| (803) 774-4625 |
| Full Name | Mrs Nancy Yvonne Spivey |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1278 N Lafayette Dr, Sumter, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467774208 | NPI | - | NPPES |
| 6717 | Other | SC | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6717 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nancy Yvonne Spivey, PHARMD 1278 N Lafayette Dr, Pharmacy Dept, Sumter, SC 29150-2964 Ph: (803) 774-4500 | Mrs Nancy Yvonne Spivey, PHARMD 1278 N Lafayette Dr, Pharmacy Dept, Sumter, SC 29150-2964 Ph: (803) 774-4500 |
News Archive
Brain specialists associated with the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital say the ability to incorporate in real time two high-tech imaging tools into the operating room can improve the functional abilities of patients who undergo brain surgery.
As people head to the beach this summer, very few if any, really know how likely they are to develop skin cancer from their outdoor fun. That's about to change, thanks to a new discovery by an international team of scientists that makes it possible for doctors to access people's personal risk for skin cancer.
As the COVID-19 pandemic progresses, it is crucial to track the viral changes in order to link the clinical and epidemiological features of the disease with these mutations. A new study published on the preprint server bioRxiv* in September 2020 reports on a common severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutation, D614G, and its effects on the virus.
Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.
› Verified 8 days ago
Tiffany Dawn Howell, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 375 Pinewood Road, Sumter, SC 29150 Phone: 803-775-5356 | |
Carrington Royals, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 319 N Main St, Sumter, SC 29150 Phone: 803-774-4500 | |
Dr. Tiffiny Amanda Sandrapaty, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 343 Pinewood Rd, Sumter, SC 29150 Phone: 803-305-6238 | |
Ms. Paula J Stover, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1278 N Lafayette Dr, Sumter, SC 29150 Phone: 803-774-4500 | |
Meighan Price, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1990 Mccrays Mill Rd, Sumter, SC 29150 Phone: 803-934-0847 Fax: 803-934-9435 | |
Dr. Anand Vora, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1990 Mccrays Mill Rd, Sumter, SC 29150 Phone: 803-934-0847 | |
Ebony La'toya Dollard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1077 Broad St, Sumter, SC 29150 Phone: 803-788-6551 |